FDA: New Cannabis Enforcement, Research Actions Announced
Outgoing U.S. Food and Drug Administration (FDA) chief Scott Gottlieb today announced new steps towards clarifying and constructing a legal framework around cannabis and cannabis-derived products, including the formation of an exploratory group examining CBD supplements and foods, and a public hearing for “stakeholders to share their experiences and challenges with these products.”